Distribution of Intrinsic Plasmid Replicase Genes and Their Association with Carbapenem-Hydrolyzing Class D beta-Lactamase Genes in European Clinical Isolates of Acinetobacter baumannii by Towner, Kevin J. et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Distribution of Intrinsic Plasmid Replicase Genes and Their
Association with Carbapenem-Hydrolyzing Class D beta-
Lactamase Genes in European Clinical Isolates of Acinetobacter
baumannii
Citation for published version:
Towner, KJ, Evans, B, Villa, L, Levi, K, Hamouda, A, Amyes, SGB & Carattoli, A 2011, 'Distribution of
Intrinsic Plasmid Replicase Genes and Their Association with Carbapenem-Hydrolyzing Class D beta-
Lactamase Genes in European Clinical Isolates of Acinetobacter baumannii' Antimicrobial Agents and
Chemotherapy, vol. 55, no. 5, pp. 2154-2159. DOI: 10.1128/AAC.01661-10
Digital Object Identifier (DOI):
10.1128/AAC.01661-10
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
Antimicrobial Agents and Chemotherapy
Publisher Rights Statement:
''Authors may post their articles to their institutional repositories
ASM grants authors the right to post their accepted manuscripts in publicly accessible electronic repositories
maintained by funding agencies, as well as appropriate institutional or subject-based open repositories
established by a government or non-commercial entity. Since ASM makes the final, typeset articles from its
primary-research journals available free of charge on the ASM Journals and PMC websites 6 months after final
publication, ASM recommends that when submitting the accepted manuscript to PMC or institutional
repositories, the author specify that the posting release date for the manuscript be no earlier than 6 months after
the final publication of the typeset article by ASM.''
http://journals.asm.org/site/misc/ASM_Author_Statement.xhtml
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, May 2011, p. 2154–2159 Vol. 55, No. 5
0066-4804/11/$12.00 doi:10.1128/AAC.01661-10
Copyright © 2011, American Society for Microbiology. All Rights Reserved.
Distribution of Intrinsic Plasmid Replicase Genes and Their
Association with Carbapenem-Hydrolyzing Class D
-Lactamase Genes in European Clinical Isolates
of Acinetobacter baumannii
Kevin J. Towner,1* Benjamin Evans,2† Laura Villa,3 Katrina Levi,1 Ahmed Hamouda,2
Sebastian G. B. Amyes,2 and Alessandra Carattoli3
Department of Clinical Microbiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom1; Centre for
Infectious Diseases, University of Edinburgh, Edinburgh, United Kingdom2; and Department of Infectious, Parasitic and
Immuno-Mediated Diseases, Istituto Superiore di Sanita`, Rome, Italy3
Received 30 November 2010/Returned for modification 25 December 2010/Accepted 29 January 2011
Ninety-six genetically diverse multidrug-resistant clinical isolates of Acinetobacter baumannii from 25 hos-
pitals in 17 European countries were screened by PCR for specific carbapenemase-hydrolyzing class D
-lactamase (CHDL) genes and by PCR-based replicon typing for the presence of 19 different plasmid
replicase (rep) gene homology groups (GRs). Results were confirmed by DNA sequencing where necessary. All
96 isolates contained at least 1 (with a maximum of 4) of the 19 groups of rep genes. Groups detected were GR6
(repAci6; 93 isolates), GR2 (including repAci1 [67 isolates] and repAci2 [3 isolates]), GR16 (repApAB49; 12
isolates), GR12 (p2ABSDF0001; 10 isolates), GR3 (repAci3; 4 isolates), GR4 (repAci4; 3 isolates), GR10
(repAciX; 1 isolate), and GR14 (repp4AYE; 1 isolate). Variations in rep gene content were observed even among
epidemiologically related isolates. Genes encoding OXA-58-like CHDLs (22 isolates) were associated with
carriage of the repAci1, repAci3, repAci4, and repAciX genes, genes encoding OXA-40-like CHDLs (6 isolates)
were associated with repAci2 and p2ABSDF0001, and genes encoding OXA-23-like CHDLs (8 isolates) were
associated with repAci1. Most intrinsic Acinetobacter plasmids are non-self-transferable, but the almost ubiq-
uitous repAci6 gene was strongly associated with a potential tra locus that could serve as a general system for
plasmid mobilization and consequent horizontal transmission of plasmids and their associated antibiotic
resistance genes among strains of A. baumannii.
Health care-associated infection with Acinetobacter bauman-
nii is a rapidly increasing problem worldwide (9, 22, 23, 29).
For several decades, large proportions of A. baumannii isolates
from health care facilities have exhibited resistance to most
commonly used antibiotics, including aminopenicillins, ureido-
penicillins, broad-spectrum cephalosporins, most aminoglyco-
sides, quinolones, tetracyclines, and chloramphenicol (3, 20,
22, 33). As a consequence, carbapenems (especially imipenem
and meropenem) have been the mainstay of treatment for
Acinetobacter infections. However, reports of resistance to car-
bapenems have accumulated worldwide, with some isolates
now being resistant to all conventional antibiotics (8, 10, 19, 25,
30). A. baumannii seems to be particularly adept at acquiring
and expressing new mechanisms of resistance in response to
challenge with novel antibiotics. It is therefore important to
understand the mechanisms of acquisition of resistance genes
by A. baumannii and to elucidate the rate and nature of genetic
exchanges.
Comparative genomic analysis of a small number of clinical
A. baumannii isolates previously revealed a poor correlation
between genetic relatedness and patterns of antimicrobial sus-
ceptibility (1, 17, 35). Furthermore, a study involving whole-
genome sequence analysis of six closely related clinical isolates
revealed extensive divergence of the resistance genotype, with
resistance genes associated with insertion sequences, plasmids,
and a chromosomal resistance gene island all showing exten-
sive variability, suggesting rapid evolution of drug resistance
(2). Although a number of different mechanisms of resistance
to carbapenems have been reported for Acinetobacter spp.
(25), most clinically significant carbapenem resistance in this
species has been associated with plasmid-mediated acquisition
of genes encoding either class B metallo--lactamases or
carbapenem-hydrolyzing class D OXA-type -lactamases
(CHDLs), with CHDLs representing the most important and
widespread mechanism of carbapenem resistance (25). Four
major groups of acquired CHDLs have been identified in A.
baumannii, represented by OXA-23, OXA-40, OXA-58, and
OXA-143 (16, 24). These acquired CHDL genes often remain
plasmid carried but can also become integrated into the bac-
terial chromosome (24), perhaps under antibiotic selection
pressure following plasmid vector instability. In addition, all
isolates of A. baumannii possess an intrinsic chromosomally
located blaOXA-51-like CHDL-encoding gene that is capable of
reducing susceptibility to carbapenems when it is overex-
pressed in conjunction with a promoter supplied by an up-
stream insertion sequence, ISAba1 (11, 12, 32). Although orig-
inally chromosomally located and found solely in A.
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baumannii, blaOXA-51-like CHDL-encoding genes linked to
ISAba1 have now also been reported to be carried on plasmids
isolated from several different Acinetobacter spp. in Taiwan,
including A. baumannii, and have been associated directly with
high levels of carbapenem resistance (6).
Plasmids are notoriously difficult to isolate and study in
Acinetobacter spp. However, an early study in 1985 with the
genus Acinetobacter (predating the delineation of A. baumannii
as a separate species) revealed that many different plasmid
incompatibility groups found in the Enterobacteriaceae are ca-
pable of transfer from Escherichia coli to the Acinetobacter
genus (7). However, the subsequent behavior of enterobacte-
rial plasmids in Acinetobacter (stability, retransfer, ability to be
mobilized, etc.) varied greatly and was influenced by the pres-
ence/absence of intrinsic plasmids in the strain of Acinetobacter
investigated (7). In the subsequent 25 years, no extensive sur-
veys have been published concerning the distribution and ep-
idemiology of particular intrinsic plasmid types in Acinetobac-
ter spp., although analysis of the fingerprint size profiles of
intrinsic plasmids has been proposed as a typing method for
clinical isolates of Acinetobacter spp. (27, 28). However, se-
quence analysis has indicated that A. baumannii plasmid rep-
licons differ from all those described previously for other pro-
karyotic species, indicating that A. baumannii possesses its own
complement of distinct plasmid types (5). The development of
a comprehensive PCR-based replicon typing method has now
provided a new tool for large-scale investigations of the epi-
demiology of intrinsic plasmids in A. baumannii. The aim of
the present study was to exploit the new multiplex replicon
typing system (5) to examine the distribution and epidemiology
of intrinsic plasmid replicase (rep) genes in 96 genotypically
diverse clinical isolates of A. baumannii from 25 hospitals in 17
European countries. In addition, the potential association of
individual plasmid rep gene groups with the horizontal dissem-
ination of genes encoding CHDLs among A. baumannii strains
was investigated.
MATERIALS AND METHODS
Bacterial isolates. The panel of A. baumannii isolates used in this study
comprised 96 well-characterized multidrug-resistant clinical isolates obtained
from patients with a range of invasive infections who were hospitalized in 25
hospitals in 17 different European countries (Table 1). The isolates were col-
lected on the basis of their reported carbapenem resistance as part of the
European Union-funded Antibiotic Resistance Prevention and Control
(ARPAC) project (21, 31), but they also exhibited resistance to aminopenicillins,
ureidopenicillins, broad-spectrum cephalosporins, aminoglycosides, quinolones,
tetracyclines, and chloramphenicol. The isolates were genotypically diverse, be-
longing to 17 different pulsed-field gel electrophoresis (PFGE) groups, including
PFGE groups forming part of the epidemic European clonal (EC) or worldwide
(WW) lineages 1, 2, and 3 (31). Multilocus sequence typing (MLST) sequence
types were assigned previously to 45 of the isolates included in the panel (14),
with at least 13 different MLST types being represented (Table 1). Epidemio-
logically related isolates (belonging to the same PFGE group) from different
patients in the same hospital were included in the panel of isolates in order to
examine short-term variation in plasmid rep gene content (Table 1).
AB-PBRT. In total, 19 PCR amplifications were used as described previously
(5) to detect 27 different plasmid rep genes, originally identified from the pub-
lished sequences of partially or fully sequenced plasmids isolated from Acineto-
bacter spp. The A. baumannii PCR-based replicon typing (AB-PBRT) scheme
groups the 27 rep genes into 19 homology groups (GRs) on the basis of their
nucleotide sequence similarities. These groups are then detected using six mul-
tiplex PCRs, each recognizing three or four different homology groups (Table 2).
DNA extracts were prepared from overnight nutrient broth cultures by use of
a Wizard DNA extraction kit (Promega, Southampton, United Kingdom). PCRs
were performed using Ready-To-Go PCR beads (GE Healthcare Life Sciences,
Little Chalfont, United Kingdom), together with previously described primers
(5), in a final volume of 25 l on a Progene thermal cycler (Techne, Cambridge,
United Kingdom). PCR conditions were as follows: 94°C for 5 min, 30 cycles of
95°C for 30 s, 54°C for 20 s, and 72°C for 45 s, and a final extension at 72°C for
5 min. PCR products were visualized by ethidium bromide staining following
electrophoresis on 1.5% (wt/vol) agarose gels in Tris-borate electrophoresis
buffer. Plasmid rep gene controls are listed in Table 2.
Some GRs contained more than one rep gene variant (Table 2). These were
distinguished by purifying the amplicons with a QIAquick PCR purification kit
(Qiagen, Crawley, United Kingdom), followed by sequencing in both directions
on a model 3730 DNA analyzer (Applied Biosystems, Warrington, United King-
dom).
Detection of plasmid-mediated tra locus. An additional PCR was designed to
identify the gene encoding the type IV secretory pathway VirB4 component, also
called type IV secretion system protein TraC, found on plasmid pACICU2
(which also carries the repAci6 gene). Primers were designed from the published
sequence (GenBank accession number CP000865.1) to amplify a 639-bp product
and were as follows: forward, 5-AACAAAGCAAGAATAAAGC-3; and re-
verse, 5-AAATCAATTGCTTGTCCTTT-3. PCR parameters were as de-
scribed above, but with an annealing temperature of 50°C.
Detection of genes encoding CHDLs. A multiplex PCR (34) was used to screen
the isolates for the presence of the four main groups of CHDLs reported for A.
baumannii, namely, the intrinsic blaOXA-51-like gene, until recently found only in
A. baumannii (6, 14, 15), and the three main families of acquired CHDL genes
(blaOXA-23-like, blaOXA-40-like, and blaOXA-58-like). A separate PCR (16) was used
to screen the isolates for the presence of the gene encoding OXA-143, which to
date is the sole representative of a new subgroup of CHDLs found in A. bau-
mannii isolates from Brazil (16).
RESULTS AND DISCUSSION
Distribution of intrinsic plasmid rep genes. All 96 isolates of
A. baumannii investigated contained at least 1 (with a maxi-
mum of 4) of the 19 groups of plasmid rep genes. Table 3
summarizes the plasmid rep gene profiles detected, grouping
the geographically related isolates that exhibited identical rep
gene profiles. In some cases (e.g., isolates A372 and A373 and
isolates A473 and A474), genotypically distinct isolates from
the same hospital were found to have identical plasmid rep
gene profiles. In contrast (e.g., the A422 group and the A425
group), isolates with the same PFGE type that were obtained
from patients in the same hospital were found to have different
plasmid rep gene profiles (Table 3), thereby indicating that
these intrinsic plasmid rep gene profiles could be unstable in
even a relatively short-term epidemiological setting. Although
it is not known whether these rep genes always exist on auton-
omous plasmid replicons or whether they sometimes be-
come integrated into the chromosome as a result of plasmid
replicon instability, the apparent potential short-term insta-
bility of the intrinsic plasmid complement is in agreement
with the extensive divergence of resistance genotypes re-
vealed by whole-genome sequence analysis of six closely
related clinical isolates (2).
Table 4 summarizes the relative distribution of the plasmid
rep genes detected in the overall collection of A. baumannii
isolates. GR6 (repAci6) was almost ubiquitous (93 of 96 iso-
lates), followed by GR2 (repAci1 and repAci2, together found
in 70 isolates). Six other rep gene groups were also detected,
but none was found in more than 12 isolates (Table 4). With
few exceptions, most intrinsic Acinetobacter plasmids seem to
be non-self-transferable in the laboratory, a finding which has
been supported by the failure of in silico analysis to detect
putative conjugation systems in most instances (5). However,
comparative analysis of plasmid and chromosome sequence
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data available for the genus Acinetobacter has revealed that the
absence of mobilization and transfer functions on most acin-
etobacter plasmids does not seem to have posed a particular
barrier to horizontal gene transfer (13).
A notable exception is the repAci6 gene. This gene was
originally identified on plasmid pACICU2, which also carries a
putative tra gene and is therefore potentially transferable (18).
The repAci6 gene was also identified as the unique rep gene
carried by four plasmids that were successfully transferred in
mating experiments, thereby confirming the association of the
repAci6 gene with the self-transferability property of this A.
baumannii plasmid group (5). Further PCR analysis of the
isolates in the present study that carried the repAci6 gene
revealed that 88 of these 93 isolates also carried a gene encod-
ing the type IV secretion system protein TraC. The three
isolates that did not carry the repAci6 gene also lacked the
gene encoding TraC. Thus, the repAci6 gene was strongly
linked with the gene encoding TraC, and the almost ubiquitous
occurrence of the repAci6 gene (93 of 96 clinical isolates in the
present study) could therefore indicate the presence of a com-
mon plasmid with the potential to mobilize other plasmids,
including plasmids carrying genes encoding a range of resis-
tance determinants, such as CHDLs.
Distribution of genes encoding CHDLs. All 96 isolates car-
ried a blaOXA-51-like gene, normally considered to be an intrin-
sic chromosomally located gene that is diagnostic of A. bau-
mannii (6, 14, 15). The associations of plasmid rep genes with
genes encoding acquired CHDLs are summarized in Tables 3
and 5. Genes encoding OXA-58-like CHDLs were most com-
mon (22 isolates) and were associated with carriage of repAci6,
repAci1, repAci3, repAci4, and repAciX. Genes encoding
OXA-23-like CHDLs (8 isolates) were associated with repAci6
and repAci1. Genes encoding OXA-40-like CHDLs (6 isolates)
were associated with carriage of repAci6, repAci2, and
TABLE 1. Clinical isolates of A. baumannii included in this study (n  96)b
Isolate(s) Sourcea Imipenem MIC(g/ml) PFGE type
EC or WW
lineage MLST type
A369, A370 Spain 128 I 2 NA
A371 Czech Republic 4 III 2 92
A372 Greece (hospital 1) 32 IV 1 NA
A373 Greece (hospital 1) 32 XVI 2 NA
A374 Netherlands 32 X New 249
A376 Austria 32 XIII New NA
A377 Germany (hospital 1) 32 XI 3 187
A380, A381, A382, A383 United Kingdom 16 XVI 2 NA
A384 Norway 16 VI 1 95
A385, A387 Greece (hospital 2) 16 XVI 2 189
A386 Greece (hospital 2) 16 IV 1 NA
A388 Greece (hospital 2) 16 IV New 248
A389 Denmark 8 XV New NA
A390, A391 Bulgaria (hospital 1) 16 VII 1 NA
A392 Germany (hospital 2) 64 IV 2 98
A393 Germany (hospital 2) 32 XV 2 NA
A394, A395, A396, A397, A398 Greece (hospital 3) 16 IV 2 4
A399, A400 Turkey 16 X New NA
A404, A405, A406, A407, A408, A409 Poland (hospital 1) 4 VIII 1 245
A410 Poland (hospital 1) 4 XV 2 NA
A411, A412, A413 Poland (hospital 1) 4 VII 1 NA
A414, A415 Poland (hospital 2) 4 VII 1 NA
A416, A417, A418, A419, A420, A421 Poland (hospital 2) 8 II 2 NA
A422, A423, A424, A425, A426, A427, A428,
A429, A430, A431, A432, A433, A434,
A435, A436, A437
Croatia 8 V 1 246
A438, A439, A440, A441, A442 Bulgaria (hospital 2) 16 IX 1 109
A443 Slovenia 8 VII 1 245
A444, A445, A446, A447, A448, A449, A450,
A451, A452
Poland (hospital 3) 8 XVII 1 NA
A453, A454 Slovakia 8 III 2 NA
A457 Estonia 4 XII New 243
A458, A459 Estonia 8 XII 1 NA
A461, A462, A463, A464, A465, A466, A467 Portugal 8 XIV New NA
A468 Poland (hospital 4) 4 VIII 2 NA
A469 Poland (hospital 4) 4 XVI 1 NA
A470 Poland (hospital 4) 8 XVII 2 NA
A472 Poland (hospital 5) 8 VIII 1 245
A473 Poland (hospital 5) 4 XVI 2 252
A474 Poland (hospital 5) 4 XVII 2 NA
a Isolates from the same country were from a single hospital, except where indicated.
b MLST types shown are those now permanently allocated in the Acinetobacter MLST database (http://pubmlst.org/abaumannii/) and differ from those published
previously (14). PFGE types and EC or WW lineages shown are as determined previously (14, 31). “New” denotes an isolate that did not belong to EC (WW) lineage
1, 2, or 3. NA, isolate has not yet been assigned to an MLST type.
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p2ABSDF0001. None of the 96 European isolates of A. bau-
mannii examined in the present study was found to carry a
gene encoding OXA-143.
Carbapenem resistance in A. baumannii can be multifacto-
rial, sometimes involving a combination of enzymatic and
other mechanisms, such as permeability, outer membrane pro-
teins, and penicillin-binding proteins (25). The isolates with
imipenem MICs of 16 g/ml, which would be regarded as
resistant according to CLSI criteria, were almost exclusively
(26/28 isolates [92.9%]) associated with the carriage of an
acquired class D carbapenemase. However, all 96 isolates also
carried an intrinsic OXA-51-type carbapenemase, whose en-
hanced expression has been shown to be capable of conferring
a carbapenem MIC of 64 g/ml in A. baumannii (6, 11, 12). It
therefore seems likely that this mechanism could be responsi-
ble for resistance in the two remaining isolates with imipenem
MICs of 16 g/ml. Interestingly, some of the 96 isolates,
which were initially selected on the basis of their resistance to
carbapenems, were found to have imipenem MICs of 4
g/ml (Table 1), perhaps indicating the instability of this form
of resistance in the absence of continued selection pressure.
Apart from carbapenem resistance, the multidrug resistance
phenotype of these isolates meant that it was not possible to
identify any correlation between the presence of particular
intrinsic plasmid rep genes and the presence of other antibiotic
resistance genes.
The repAci1 and repAci2 genes are found mostly on plasmids
that also carry the Re27 sequence (26). Although very few
Acinetobacter plasmids carrying genes encoding CHDLs have
been sequenced fully, the 27-bp Re27 sequence seems to de-
note a favored insertion site for structures carrying OXA-58-
like CHDL genes. For example, in strain MAD from France,
the genetic structure surrounding the OXA-58 gene is brack-
eted by two copies of the Re27 sequence (26). Similar struc-
tures have been identified in isolates from Italy and Lebanon
(4, 36), and it has been suggested that a site-specific recombi-
TABLE 2. Plasmid replicon typing scheme for A. baumannii based
on the sequences of 19 different groups of rep genes
Multiplex
no. Group
Amplicon
size (bp)a Plasmid replicase
Control strain or
plasmid
1 GR1 330 p1ABSDF001 SDF
GR3 505 Aci3  Aci7 Ab537
GR2 851 Aci1  Aci2 AYE
2 GR5 220 Aci5 Ab537
GR18 676 p2ABSDF00025 SDF
GR7 885 p3ABSDF002 SDF
3 GR9 191 p3ABSDF0009 SDF
GR4 508 Aci4 Ab844
GR11 852 p1ABAYE0001 AYE
4 GR12 165 p2ABSDF0001 SDF
GR10 371 AciX ACICU
GR13 780 p3ABAYE0002 AYE
5 GR8 233 Aci8  Aci9 (RepM) Ab11921
GR14 622 p4ABAYE0001 AYE
GR15 876 p3ABSDF0018 SDF
6 GR16 233 RepApAB49 pAB49
GR17 380 A1s_3471 ATCC17978
GR6 662 Aci6 ACICU
GR19 815 Rep135040 Ab135040
a Primers used to detect individual rep genes were those described previ-
ously (5).
TABLE 3. Results of rep and CHDL gene analyses of 96 European
isolates of A. baumannii, grouped according to rep
gene content and geographical relationships
Isolate(s)
repAci gene
content
(GR no.)
CHDL
contenta
A369, A370 6, 12 OXA-40
A371 6
A372, A373 1, 6 OXA-58
A374 1, 6 OXA-23
A376 12
A377 2, 6 OXA-58
A380, A381, A382, A383 1, 6 OXA-23,
OXA-58
A384 6, 12 OXA-58
A386 1, 10 OXA-58
A385, A387 1, 6 OXA-58
A388 1, 6 OXA-58
A389 3 OXA-58
A390, A391 1, 6 OXA-23
A392, A393 6 OXA-58
A394, A395, A396, A397, A398 1, 6 OXA-58
A399, A400 3, 6, 4, 12 OXA-58
A404, A405, A406, A407, A408, A409,
A410, A411, A412, A413
1, 6
A414, A415, A416, A417, A418, A419,
A420, A421
1, 6
A422, A423, A424, A435, A436 1, 6
A425, A426, A427, A428, A429, A430,
A431, A432, A433, A434, A437
1, 6, 16
A438, A439, A441, A442 1, 6, 16
A440 6 OXA-23
A443 6
A445, A446, A447, A448, A449, A450,
A451, A452
1, 6
A453, A454 6
A457 3, 6
A458, A459 6
A461 4, 6, 12, 14 OXA-58
A462, A463, A466 1, 6, 12
A464, A465, A467 6 OXA-40
A468, A470 1, 6, 16
A469 1, 6
A472 1, 6
A473, A474 6
a All isolates also carried a gene encoding an intrinsic OXA-51-like CHDL.
TABLE 4. Overview of plasmid rep gene distribution among 96
clinical isolates of A. baumannii
GR no., rep gene detected No. (%) of isolates
GR6, repAci6 .........................................................................93 (96.8)
GR2, repAci1 .........................................................................67 (69.8)
GR2, repAci2 ......................................................................... 3 (3.1)
GR16, repApAB49 ................................................................12 (12.5)
GR12, p2ABSDF0001 ..........................................................10 (10.4)
GR3, repAci3 ......................................................................... 4 (4.2)
GR4, repAci4 ......................................................................... 3 (3.1)
GR10, repAciX ...................................................................... 1 (1.1)
GR14, p4ABAYE0001 ......................................................... 1 (1.1)
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nation process could be involved in the acquisition of the
blaOXA-58 locus (4, 26, 36). The finding in the present study
that the repAci1/repAci2 group was associated with 14 of the 22
isolates that encoded OXA-58-like CHDLs (Table 5) provides
further support for this suggestion. Similar processes are prob-
ably involved in the acquisition of genes encoding OXA-23-like
and OXA-40-like CHDLs. Thus, although CHDL genes were
also associated occasionally with the presence of other plasmid
rep genes, the presence of repAci1 or repAci2 not only reflects
the fact that acquired CHDL genes have been reported mostly
for plasmids that also carry the linked Re27 sequence but also
may indicate a particular propensity for strains to acquire such
genes. Furthermore, the presence of acquired CHDL genes
was almost always (34 of 36 isolates) associated with repAci6,
linked in turn to a potential conjugation system that could act
to mobilize other plasmids present in the same cell.
Conclusions. The AB-PBRT system was found to be an easy,
rapid, and reliable tool for large-scale investigations of the
epidemiology of intrinsic plasmid rep genes in clinical isolates
of A. baumannii. Specific rep genes were detected in all 96 of
the genotypically diverse European clinical isolates of A. bau-
mannii examined in the present study, with some isolates car-
rying as many as four different plasmid rep gene types. Genes
encoding CHDLs such as OXA-58 were particularly associated
with carriage of the repAci1 gene, which in turn probably
reflects their linkage with the Re27 sequence, which seems to
denote a favored insertion site for molecular structures carry-
ing genes encoding CHDLs (26).
A. baumannii is well known for the speed with which it
appears able to acquire and express new mechanisms of resis-
tance in response to challenge with novel antibiotics. In this
respect, the diverse nature of the intrinsic plasmid complement
in this species, as indicated by the detection of different rep
genes in the clinical isolates examined in the present study,
suggests that there is an enhanced basis for genomic rearrange-
ments and incorporation of new resistance genes, perhaps at
insertion sites such as the Re27 sequence. Of particular inter-
est was the almost ubiquitous occurrence of the repAci6 gene,
which could be indicative of the presence of a general intrinsic
system for plasmid mobilization and consequent horizontal
transmission of foreign plasmids and their associated antibiotic
resistance genes among clinical strains of A. baumannii. Fur-
ther studies will be required to elucidate the precise genetic
linkage between particular rep genes and individual antibiotic
resistance determinants in order to elucidate the rate and
nature of genetic exchanges. However, the results of the pres-
ent study with clinical isolates of A. baumannii provide further
evidence for the potential within this genus for very dynamic
reorganization and flexibility of plasmid architecture under
fluctuating environmental and selective conditions (13).
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